IMMUNE PHARMACEUTICALS INC. (NASDAQ:IMNP) Files An 8-K Submission of Matters to a Vote of Security Holders

0

IMMUNE PHARMACEUTICALS INC. (NASDAQ:IMNP) Files An 8-K Submission of Matters to a Vote of Security Holders

Item 5.07

Submission of Matters to a Vote of Security
Holders.

On December 20, 2016, Immune Pharmaceuticals Inc. (the Company)
held its 2016 Annual Meeting of Stockholders (the Annual
Meeting). At the Annual Meeting, the holders of 78,497,800 shares
of the voting stock of the Company were present in person or
represented by proxy, which represents approximately 63% of the
total shares of outstanding stock entitled to vote as of the
record date of October 21, 2016.

The following actions were taken in the Annual Meeting:

(1) The selection of BDO USA, LLP as the Companys independent
registered public accounting firm for the fiscal year ending
December 31, 2016, was ratified, based on the following
votes:
Votes For Votes Against Votes Abstain Broker Non-Vote
74,558,639 2,232,794 1,706,367
(2) The increase in the amount of shares authorized under the
Immune Pharmaceuticals Inc. 2015 Equity Incentive Plan from
5,000,000 shares to 15,000,000 shares was approved, based on
the following votes:
Votes For Votes Against Votes Abstain Broker Non-Vote
38,243,946 9,238,861 2,292,644 28,722,349
(3) The following two Class III nominees were reelected to serve
on the Companys Board of Directors until the Companys 2019
annual meeting of stockholders or until their respective
successors have been elected and qualified:
Name of Director Nominees Votes For Votes Abstain Broker Non-Vote
Daniel G. Teper 48,597,134 1,178,317 28,722,349
John Neczesny 35,953,441 13,822,010 28,722,349
(4) The authorization of the filing of an amendment to the
Companys Certificate of Incorporation to effect a reverse
stock split of the Companys common stock at a specific ratio,
within a range of 1-for-2 and 1-for-25, to be determined by
the Companys Board of Directors in its sole discretion and
effected, if at all, on or before December 15, 2017 was
approved, based on the following votes:
Votes For Votes Against Votes Abstain Broker Non-Vote
62,751,519 13,102,528 2,643,750



About IMMUNE PHARMACEUTICALS INC. (NASDAQ:IMNP)